Julio Pardo

3.0k total citations
27 papers, 1.0k citations indexed

About

Julio Pardo is a scholar working on Neurology, Cellular and Molecular Neuroscience and Molecular Biology. According to data from OpenAlex, Julio Pardo has authored 27 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Neurology, 13 papers in Cellular and Molecular Neuroscience and 7 papers in Molecular Biology. Recurrent topics in Julio Pardo's work include Peripheral Neuropathies and Disorders (8 papers), Hereditary Neurological Disorders (7 papers) and Genetic Neurodegenerative Diseases (5 papers). Julio Pardo is often cited by papers focused on Peripheral Neuropathies and Disorders (8 papers), Hereditary Neurological Disorders (7 papers) and Genetic Neurodegenerative Diseases (5 papers). Julio Pardo collaborates with scholars based in Spain, United States and Switzerland. Julio Pardo's co-authors include Isabel Illa, Luís Querol, María J. Sedano, Jordi Díaz‐Manera, Eduard Gallardo, A Ortega-Moreno, Ricardo Rojas‐García, Gisela Nogales‐Gadea, Rafael Blesa and José Berciano and has published in prestigious journals such as SHILAP Revista de lepidopterología, Brain and Neurology.

In The Last Decade

Julio Pardo

24 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Julio Pardo Spain 15 698 553 192 122 100 27 1.0k
Marina Grandis Italy 20 452 0.6× 644 1.2× 353 1.8× 81 0.7× 64 0.6× 79 1.2k
Francesca Madia Italy 18 438 0.6× 290 0.5× 351 1.8× 81 0.7× 50 0.5× 62 1.0k
P. D. Donofrio United States 10 740 1.1× 465 0.8× 156 0.8× 210 1.7× 62 0.6× 14 996
F Barbieri Italy 21 368 0.5× 496 0.9× 320 1.7× 48 0.4× 248 2.5× 65 1.4k
Susanna Ruggero Italy 16 378 0.5× 121 0.2× 155 0.8× 74 0.6× 69 0.7× 31 844
J. C. Antoine France 15 1.3k 1.8× 578 1.0× 331 1.7× 41 0.3× 20 0.2× 28 1.6k
Elio Maccagnano Italy 14 367 0.5× 128 0.2× 256 1.3× 85 0.7× 33 0.3× 25 792
Eric Schmedding Belgium 14 214 0.3× 359 0.6× 264 1.4× 31 0.3× 87 0.9× 33 827
Anna Sagnelli Italy 13 275 0.4× 174 0.3× 227 1.2× 45 0.4× 42 0.4× 22 642
S Stefanko Netherlands 19 449 0.6× 168 0.3× 298 1.6× 113 0.9× 250 2.5× 45 1.5k

Countries citing papers authored by Julio Pardo

Since Specialization
Citations

This map shows the geographic impact of Julio Pardo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Julio Pardo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Julio Pardo more than expected).

Fields of papers citing papers by Julio Pardo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Julio Pardo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Julio Pardo. The network helps show where Julio Pardo may publish in the future.

Co-authorship network of co-authors of Julio Pardo

This figure shows the co-authorship network connecting the top 25 collaborators of Julio Pardo. A scholar is included among the top collaborators of Julio Pardo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Julio Pardo. Julio Pardo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cortés‐Vicente, Elena, et al.. (2024). Consensus recommendation for the treatment of generalised Myasthenia Gravis with anti-acetylcholine receptor antibodies (gMG AChR+) in Spain. SHILAP Revista de lepidopterología. 3. 100051–100051.
2.
Navas‐Sánchez, Francisco J., Daniel Martín de Blas, Yasser Alemán‐Gómez, et al.. (2021). Thalamic atrophy in patients with pure hereditary spastic paraplegia type 4. Journal of Neurology. 268(7). 2429–2440. 9 indexed citations
3.
Arias, Manuel, Raquel Cruz, Beatriz Quintáns, et al.. (2020). Cerebellar Cognitive Affective Syndrome in Costa da Morte Ataxia (SCA36). The Cerebellum. 19(4). 501–509. 9 indexed citations
4.
Lupo, Vincenzo, Marina Frasquet, Ana L. Pelayo‐Negro, et al.. (2018). Characterising the phenotype and mode of inheritance of patients with inherited peripheral neuropathies carrying MME mutations. Journal of Medical Genetics. 55(12). 814–823. 15 indexed citations
5.
Cortés‐Vicente, Elena, Ricard Rojas‐García, Jordi Díaz‐Manera, et al.. (2018). The impact of rituximab infusion protocol on the long‐term outcome in anti‐MuSK myasthenia gravis. Annals of Clinical and Translational Neurology. 5(6). 710–716. 36 indexed citations
6.
Sánchez‐Iglesias, Sofía, Antonio Mera, E. Pintos, et al.. (2018). Inflammatory myopathy in the context of an unusual overlapping laminopathy. Archives of Endocrinology and Metabolism. 62(3). 376–382. 7 indexed citations
7.
García‐Sobrino, Tania, Patricia Blanco, Francesc Palau, et al.. (2017). Phenotypical features of a new dominant GDAP1 pathogenic variant (p.R226del) in axonal Charcot-Marie-Tooth disease. Neuromuscular Disorders. 27(7). 667–672. 6 indexed citations
8.
9.
Aguiar, Pablo, Julio Pardo, Manuel Arias, et al.. (2016). PET and MRI detection of early and progressive neurodegeneration in spinocerebellar ataxia type 36. Movement Disorders. 32(2). 264–273. 14 indexed citations
10.
Querol, Luís, Gisela Nogales‐Gadea, Ricardo Rojas‐García, et al.. (2014). Neurofascin IgG4 antibodies in CIDP associate with disabling tremor and poor response to IVIg. Neurology. 82(10). 879–886. 276 indexed citations
11.
Pardo, Julio, et al.. (2014). Can we predict the response in the treatment of epilepsy with vagus nerve stimulation?. Neurosurgical Review. 37(4). 661–668. 19 indexed citations
12.
Rodríguez‐Osorio, Xiana, et al.. (2013). Levetiracetam following liver and kidney failure in late-onset anticonvulsant hypersensitivity syndrome. Journal of Clinical Neuroscience. 21(5). 859–860. 3 indexed citations
13.
García-Murias, María, Beatriz Quintáns, Manuel Arias, et al.. (2012). ‘Costa da Morte’ ataxia is spinocerebellar ataxia 36: clinical and genetic characterization. Brain. 135(5). 1423–1435. 64 indexed citations
14.
Sierra‐Marcos, Alba, Iratxe Maestro, Xiana Rodríguez‐Osorio, et al.. (2012). Successful outcome of episodes of status epilepticus after vagus nerve stimulation: a multicenter study. European Journal of Neurology. 19(9). 1219–1223. 14 indexed citations
15.
Falip, Mercè, Vicente Villanueva, Pilar de la Peña, et al.. (2010). Efficacy of intravenous levetiracetam as an add-on treatment in status epilepticus: A multicentric observational study. Seizure. 20(1). 60–64. 33 indexed citations
16.
Corominas, Roser, Marta Ribasès, Ester Cuenca-León, et al.. (2009). Two-stage case-control association study of dopamine-related genes and migraine. BMC Medical Genetics. 10(1). 95–95. 25 indexed citations
17.
Arias, Manuel, Julio Pardo, Patricia Blanco, et al.. (2006). Distinct phenotypic features and gender-specific disease manifestations in a Spanish family with desmin L370P mutation. Neuromuscular Disorders. 16(8). 498–503. 20 indexed citations
18.
Pedro‐Cuesta, Jesús de, J.R. Ara, Carlos Cemillán, et al.. (2004). Public health surveillance and incidence of adulthood Guillain-Barré syndrome in Spain, 1998–1999: the view from a sentinel network of neurologists. Neurological Sciences. 25(2). 57–65. 27 indexed citations
19.
Pedro‐Cuesta, Jesús de, J.R. Ara, Carlos Cemillán, et al.. (2001). Guillain-Barré Syndrome in Spain, 1985–1997: Epidemiological and Public Health Views. European Neurology. 46(2). 83–91. 24 indexed citations
20.
Pardo, Julio, Ángel Carracedo, Irene Muñoz, et al.. (1995). Genetic Markers: Association Study in Migraine. Cephalalgia. 15(3). 200–204. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marina Grandis Breakdown of academic impact, for papers by Francesca Madia Breakdown of academic impact, for papers by P. D. Donofrio Breakdown of academic impact, for papers by F Barbieri Breakdown of academic impact, for papers by Susanna Ruggero Breakdown of academic impact, for papers by J. C. Antoine Breakdown of academic impact, for papers by Elio Maccagnano Breakdown of academic impact, for papers by Eric Schmedding Breakdown of academic impact, for papers by Anna Sagnelli Breakdown of academic impact, for papers by S Stefanko
Rankless by CCL
2026